In Vitro Toxicity Testing Market: Report – key Players, Industry Overview And Forecasts To 2025

In Vitro Toxicity Testing Market: Overview

Several changes are taking place in the pharmaceutical industry, in order to improve efficiency and reduce cost, besides several drug developments and testing. High rate of attrition in drug development in the last two decades, especially when the drug reaches the later stages of development, is a major concern for the pharmaceutical industry. As a result, the heavy cost on research and development is incurred exceedingly on the pharmaceutical company. Thus, the pharmaceutical industry is constantly in the need of finding reasons for attrition failures.

Download PDF Brochure of Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=395
However, the adoption of in vitro ADME screening into drug discovery programs have reduced this drug failure up to an extent. In 1991, 40% of clinical trial failures were due to poor pharmacokinetics. By, 2000 this number was reduced to 10% and this happened with the advent of in vitro ADME. In vitro ADME has been widely accepted in the pharmaceutical industry and its value has been recognized in the last five years. Some new cellular models and techniques have expanded the market of in vitro toxicology and this market is expected to grow a CAGR of 15.3% from 2013 to 2018. The later stage attrition can be overcome by the advent and subsequent growth of the in vitro toxicology testing methods.

There are several advantages of the in vitro toxicology approach as it has improved the overall predictive quality because human cells are being used. Moreover, this method is cost effective and is less time consuming as compared to the animal testing methods. Earlier, the methods for predicting toxicity in humans were same for testing toxicity in animals, but there are many chemicals that are toxic to one and non toxic to another and vice versa. It creates a lot more confusion in the testing and development of new drugs. Thus, the testing that is been conducted on human cells gives better opportunity to understand and improve the predictions of toxicity in humans. Thus, these in vitro toxicology methods are likely to gain more importance in the forecasted period with the continuous advancements in technology.

Request to View Sample of Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=395

Although the in vitro toxicity market is new, it has huge potential in the future. Technological development and new product launch in this field will play a major role in this industry. However, the absence of pharmaceutical giants in this sector provides better opportunity for the new entrants to establish themselves in the market. Therefore, the company ready to invest can enter this emerging market and is likely to be successful as the market offers high potential to the new players.

In the present scenario, in vitro methods are widely used in by all regulatory bodies and industries in safety assessment, risk evaluation and toxicity testing. The main idea behind using in vitro techniques over animal testing are the advantages associated with them. The in vitro method is mainly used to elucidate mechanisms of toxicity in a drug and its effect on the cell or tissue. The development of Ames Mutagenic Assay made the non-animal testing more popular as compared to animal testing.

Furthermore, the regulatory concerns and political barriers are further expected to boost this market. Ethical concerns related to animals are one of the key factors in many countries that are likely to drive this market. The regulations are strict for animal testing in the countries such as Europe and the companies operating in this region are bound to ignore and move away from animal testing and choose in vitro toxicology testing for several product developments and research areas. Similarly, other emerging nations of Asia are also expected to follow suit and thus lead to better and rapid growth of in vitro testing methods in these regions.  Also, better economic conditions in this region will be highly supporting in adoption of this new technology and thus new developments in the pharmaceutical, chemicals, cosmetics and food industries will emerge rapidly in the future.

Request to View Discount –
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=395

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.